Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings yield high or low?
The earnings yield of 1.28% is in line with its 1-year average of 1.38%, near the low end of its 1-year range (1.11%–1.79%).
As of 2026-10-06T18:06:43.396Z.
Calculation as of: 2026-10-06T18:06:43.396Z.
Quote observation: 2026-10-06T18:05:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 604c485faa117edd7b478e74db8828d7312282746a460099f8cc32b45e3ebf42
EARNINGS YIELD
1.28%
EARNINGS YIELD AVG TTM
N/A
EARNINGS YIELD AVG 3Y
N/A
EARNINGS YIELD AVG 5Y
N/A
EARNINGS YIELD AVG 10Y
N/A
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.91%
median of 186 covered companies
CURRENT VS SECTOR MEDIAN
-67.22%
vs the sector median at left
Market Cap
$7.97B
Earnings Yield
5.26%
TTM Avg
6.84%
3Y Avg
3.59%
5Y Avg
3.59%
Market Cap
$7.70B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.62B
Earnings Yield
N/A
TTM Avg
2.30%
3Y Avg
2.30%
5Y Avg
2.30%
Market Cap
$7.33B
Earnings Yield
N/A
TTM Avg
2.04%
3Y Avg
3.02%
5Y Avg
2.45%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caris Life Sciences, Inc. (CAI) | $7.89B | 1.28% | N/A | N/A | N/A |
| TG Therapeutics, Inc. (TGTX)vs › | $7.97B | 5.26% | 6.84% | 3.59% | 3.59% |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.70B | N/A | N/A | N/A | N/A |
| Cytokinetics, Incorporated (CYTK)vs › | $7.62B | N/A | 2.30% | 2.30% | 2.30% |
| HealthEquity, Inc. (HQY)vs › | $7.60B | 3.05% | 2.61% | 1.55% | 1.43% |
| Hinge Health, Inc. (HNGE)vs › | $7.57B | 1.32% | 1.41% | 2.92% | 2.92% |
| Oscar Health, Inc. (OSCR)vs › | $8.35B | 4.35% | 4.52% | 2.80% | 2.80% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.33B | N/A | 2.04% | 3.02% | 2.45% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.58B | N/A | N/A | N/A | N/A |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.74B | N/A | 2.41% | 2.41% | 2.41% |
Earnings Yield
1.28%
EPS ÷ Price
P/E Ratio
78.0
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2026-10-05 | 1.18% |
| 2026-10-02 | 1.26% |
| 2026-10-01 | 1.26% |
| 2026-09-30 | 1.17% |
| 2026-09-29 | 1.13% |
| 2026-09-28 | 1.13% |
| 2026-09-25 | 1.12% |
| 2026-09-24 | 1.11% |
| 2026-09-23 | 1.13% |
| 2026-09-22 | 1.14% |
| 2026-09-21 | 1.17% |
| 2026-09-18 | 1.19% |
| 2026-09-17 | 1.16% |
| 2026-09-16 | 1.27% |
| 2026-09-15 | 1.26% |
| 2026-09-14 | 1.37% |
| 2026-09-11 | 1.47% |
| 2026-09-10 | 1.49% |
| 2026-09-09 | 1.49% |
| 2026-09-08 | 1.44% |
| 2026-09-04 | 1.43% |
| 2026-09-03 | 1.41% |
| 2026-09-02 | 1.44% |
| 2026-09-01 | 1.44% |
| 2026-08-31 | 1.40% |
| 2026-08-28 | 1.40% |
| 2026-08-27 | 1.36% |
| 2026-08-26 | 1.33% |
| 2026-08-25 | 1.28% |
| 2026-08-24 | 1.37% |
| 2026-08-21 | 1.36% |
| 2026-08-20 | 1.46% |
| 2026-08-19 | 1.57% |
| 2026-08-18 | 1.71% |
| 2026-08-17 | 1.65% |
| 2026-08-14 | 1.64% |
| 2026-08-13 | 1.61% |
| 2026-08-12 | 1.61% |
| 2026-08-11 | 1.55% |
| 2026-08-10 | 1.53% |
| 2026-08-07 | 1.57% |
| 2026-08-06 | 1.79% |
